Pete Zorn

Chief Corporate Officer and General Counsel

Pete Zorn joined Albireo in 2015 as Senior Vice President, Corporate Development and General Counsel, becoming Chief Corporate Officer and General Counsel in January 2017. Previously, he was General Counsel and Vice President, Communications at Santaris Pharma, a Denmark-headquartered company acquired by Roche in 2014. Prior to Santaris, Pete served for 11 years as General Counsel at Targacept, Inc. where he played a leadership role in a variety of significant milestones, including its company-launching spinout, IPO and additional financings, and multiple complex collaborations with major pharmaceutical companies. Pete began his career as a corporate attorney at a large law firm. He received his undergraduate degree from Harvard and his J.D. from the University of North Carolina at Chapel Hill.

Team members

Ron Cooper

President and Chief Executive Officer

Martha (Muffy) Carter

Chief Regulatory Officer

Per-Göran Gillberg, Ph.D., Prof.

Vice President, Development and Co-Founder

Jan Mattsson, Ph.D.

Chief Operating Officer and Co-Founder

Tom Shea

Chief Financial Officer

Paresh Soni, M.D., Ph.D.

Chief Medical Officer

Kristina Torfgård, Ph.D.

Vice President, Global Project Head

Pete Zorn

Chief Corporate Officer and General Counsel